Scientists have developed a gene-editing therapy to selectively disable the genetic mutations responsible for Von Willebrand disease (VWD) type 2, regardless of subtype, potentially…
A combination of the medicines eltrombopag and cyclosporine A may be effective for controlling immune thrombocytopenia (ITP) that doesn’t respond well to initial treatment with corticosteroids, though caution is needed due to a risk of life-threatening adverse events for some patients, according to a new study. The researchers noted…
Latest news & perspectives
“How are you feeling?” Who knew a simple, well-intentioned question could stir up so many emotions? I hear it several times a week, and it…
